Skip to main content
Create Account
About PLI PLUS
Help
Contact Us
Questions? Comments?
Contact us.
Email:
PLUS@pli.edu
Phone:
877.900.5291
PLI.edu
SIGN IN
Search
Browse
All Content
Books
- Answer Books
- Course Handbooks
- Journals
- Treatises
Forms
Transcripts
My Bookshelf
My History
< Back To Results
1 in 1 results
Previous Result
Next Result
Developments in Pharmaceutical and Biotech Patent Law 2016
Chair(s):
Daniel L. Reisner, David K. Barr
Practice Area:
Health Care, Intellectual Property
Published:
Dec 2016
ISBN:
9781402427824
PLI Item #:
150243
CHB Spine #:
G1296
This version is not current.
Click here for the most recent version.
Email
Print
Add To Bookshelf
Permalink
Table of Contents
Related Items
Select All
Front Matter
Faculty Bios
Table of Contents
Chapter 1. Willfulness: A Return to the Bad Old Days (2016)
Chapter 2. Chapter 14 Biologic and Biosimilar Drug Products, prepublication revision, PLI Legal Treatise, Pharmaceutical and Biotech Patent Law
Chapter 3. Local Rules of Civil Practice and Procedure of the United States District Court for the District of Delaware (August 1, 2016)
Chapter 4. L. Civ. R. 9.3—Local Patent Rules
Chapter 5. Sample Judge Waldor Pretrial Scheduling Order
Chapter 6. Sample Appendix A to Joint Discovery Plan
Chapter 7. Sample Judge Arpert Joint Discovery Plan
Chapter 8. Sample Judge Goodman Joint Discovery Plan and Proposed Scheduling Order
Chapter 9. Injunctive Relief in Pharmaceutical Patent Cases under the “Causal Nexus” Test of Apple v. Samsung (August 24, 2016)
Chapter 10. Section 101: Patentable Subject Matter in the Aftermath of Myriad and Mayo
Chapter 11. Learning to Sail Outside the Safe Harbor: Pleading Direct Patent Infringement after Abrogation of Rule 84 and Form 18
Index
About Us
